Oramed Pharmaceuticals
ORMP
#9081
Rank
S$0.21 B
Marketcap
S$5.37
Share price
3.48%
Change (1 day)
82.82%
Change (1 year)

Earnings for Oramed Pharmaceuticals (ORMP)

Earnings in 2026 (TTM): S$0.10 Billion

According to Oramed Pharmaceuticals's latest financial reports the company's current earnings are N/A. In 2025 the company made an earning of S$0.10 Billion, an increase over its 2024 earnings that were of -S$19.45 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Oramed Pharmaceuticals from 2006 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) S$0.10 B0.73%
2025 S$0.10 B-616.9%
2024 -S$19.45 Million-311.47%
2023 S$9.19 M-119.45%
2022 -S$47.29 Million39.17%
2021 -S$33.98 Million73.93%
2020 -S$19.54 Million18.53%
2019 -S$16.48 Million-16.62%
2018 -S$19.77 Million38.32%
2017 -S$14.29 Million12.51%
2016 -S$12.7 Million25.01%
2015 -S$10.16 Million18.18%
2014 -S$8.6 Million39.72%
2013 -S$6.16 Million46.4%
2012 -S$4.21 Million128.32%
2011 -S$1.85 Million-51.47%
2010 -S$3.8 Million35.21%
2009 -S$2.81 Million
2007 -S$4.42 Million607.04%
2006 -S$0.63 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Novo Nordisk
NVO
S$32.28 B 31,672.04%๐Ÿ‡ฉ๐Ÿ‡ฐ Denmark
Sanofi
SNY
S$9.88 B 9,628.39%๐Ÿ‡ซ๐Ÿ‡ท France
Ultragenyx Pharmaceutical
RARE
-S$0.7 Billion-781.59%๐Ÿ‡บ๐Ÿ‡ธ USA
Lexicon Pharmaceuticals
LXRX
-S$33.68 Million-133.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Compugen
CGEN
S$45.02 M-55.69%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel